<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32071166</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>15</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>ALS is a multistep process in South Korean, Japanese, and Australian patients.</ArticleTitle><Pagination><StartPage>e1657</StartPage><EndPage>e1663</EndPage><MedlinePgn>e1657-e1663</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000009015</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To establish whether amyotrophic lateral sclerosis (ALS) is a multistep process in South Korean and Japanese populations when compared to Australian cohorts.</AbstractText><AbstractText Label="METHODS">We generated incident data by age and sex for Japanese (collected between April 2009 and March 2010) and South Korean patients with ALS (collected between January 2011 and December 2015). Mortality rates were provided for Australian patients with ALS (collected between 2007 and 2016). We regressed the log of age-specific incidence against the log of age with least squares regression for each ALS population.</AbstractText><AbstractText Label="RESULTS">We identified 11,834 cases of ALS from the 3 populations, including 6,524 Australian, 2,264 Japanese, and 3,049 South Korean ALS cases. We established a linear relation between the log incidence and log age in the 3 populations: Australia <i>r</i> <sup><i>2</i></sup> = 0.99, Japan <i>r</i> <sup><i>2</i></sup> = 0.99, South Korea <i>r</i> <sup><i>2</i></sup> = 0.99. The estimate slopes were similar across the 3 populations, being 5.4 (95% confidence interval [CI], 4.8-5.5) in Japanese, 5.4 (95% CI, 5.2-5.7) in Australian, and 4.4 (95% CI, 4.2-4.8) in South Korean patients.</AbstractText><AbstractText Label="CONCLUSIONS">The linear relationship between log age and log incidence is consistent with a multistage model of disease, with slope estimated suggesting that 6 steps were required in Japanese and Australian patients with ALS while 5 steps were needed in South Korean patients. Identification of these steps could identify novel therapeutic strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vucic</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia. steve.vucic@sydney.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashihara</LastName><ForeName>Mana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atsuta</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Yuriko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Inah</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Ki-Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jinseok</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun Mi</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0003-4290-5441</Identifier><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Parvathi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>From the Westmead Clinical School (S.V., M.H., P.M.), University of Sydney, Australia; Department of Neurology (N.A.), Nagoya University Graduate School of Medicine (G.S.); The National Institute of Public Health (Y.D.), Wako-shi; Chiba University Graduate School of Medicine (S.K.), Japan; Department of Neurology (S.H.K., K.-W.O., J.P.), Hanyang University Hospital; Department of Health Sciences (I.K., E.M.K.), Hanyang University Graduate School; Department of Occupational and Environmental Medicine (I.K.), College of Medicine, Hanyang University, Seoul, Republic of Korea; Geelong Hospital (P.T.); and Brain and Mind Centre (M.C.K.), University of Sydney and Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PACTALS Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044469" MajorTopicYN="N">Racial Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32071166</ArticleId><ArticleId IdType="pmc">PMC7251515</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000009015</ArticleId><ArticleId IdType="pii">WNL.0000000000009015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol 2016;12:651&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. . Amyotrophic lateral sclerosis. Lancet 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin RL, Vajda A, Hardiman O. Heritability of amyotrophic lateral sclerosis: insights from disparate numbers. JAMA Neurol 2015;72:857&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">26029874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian L, Liu M, Cui L, et al. . Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in China. J Clin Neurosci 2019;66:12&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">31155341</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kiernan M, Mitsumoto H, Swash M. Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 2014;85:1232&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett SA, Tanaz R, Cobos SN, Torrente MP. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Transl Res 2019;204:19&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, et al. . Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 2014;13:1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2007940</ArticleId><ArticleId IdType="pubmed">13172380</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher JC, Hollomon JH. A hypothesis for the origin of cancer foci. Cancer 1951;4:916&#x2013;918.</Citation><ArticleIdList><ArticleId IdType="pubmed">14879355</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Westeneng HJ, Al-Chalabi A, van den Berg LH, Talman P, Kiernan MC. Amyotrophic lateral sclerosis as a multi-step process: an Australia population study. Amyotroph Lateral Scler Frontotemporal Degener 2019;8:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31284763</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mazzini L, D'Alfonso S, et al. . The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology 2018;91:e635&#x2013;e642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology 2019;52:93&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N, Sobue G, Kuwabara S, et al. . Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry 2016;87:821&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">27093948</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi Y, Atsuta N, Sobue G, Morita M, Nakano I. Prevalence and incidence of amyotrophic lateral sclerosis in Japan. J Epidemiol 2014;24:494&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213224</ArticleId><ArticleId IdType="pubmed">25373461</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun KY, Park J, Oh KW, et al. . Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 2019;90:395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581156</ArticleId><ArticleId IdType="pubmed">30409890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B, Miller R, Swash M, Munsat T. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, et al. . Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018;17:423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Talman P, Duong T, Vucic S, et al. . Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort. BMJ Open 2016;6:e012054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051496</ArticleId><ArticleId IdType="pubmed">27694488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Ziemann U, Eisen A. Amyotrophic lateral sclerosis: origins traced to impaired balance between neural excitation and inhibition in the neonatal period. Muscle Nerve 2019;60:232&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">31233613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol E. Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast 2011;2011:649325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3159129</ArticleId><ArticleId IdType="pubmed">21876820</ArticleId></ArticleIdList></Reference><Reference><Citation>Louzoun-Kaplan V, Zuckerman M, Perez-Polo JR, Golan HM. Prenatal hypoxia down regulates the GABA pathway in newborn mice cerebral cortex; partial protection by MgSO4. Int J Dev Neurosci 2008;26:77&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">17936537</ArticleId></ArticleIdList></Reference><Reference><Citation>Allain AE, Le Corronc H, Delpy A, et al. . Maturation of the GABAergic transmission in normal and pathologic motoneurons. Neural Plast 2011;2011:905624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140191</ArticleId><ArticleId IdType="pubmed">21785735</ArticleId></ArticleIdList></Reference><Reference><Citation>Brostrom L, Vollmer B, Bolk J, Eklof E, Aden U. Minor neurological dysfunction and associations with motor function, general cognitive abilities, and behaviour in children born extremely preterm. Dev Med Child Neurol 2018;60:826&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">29573402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Sun D. GABA receptors in brain development, function, and injury. Metab Brain Dis 2015;30:367&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231020</ArticleId><ArticleId IdType="pubmed">24820774</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 2013;9:617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch KE, Kemp DJ. Nature-via-nurture and unravelling causality in evolutionary genetics. Trends Ecol Evol 2014;29:2&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24211246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 2005;128:472&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Lu D, Chung YJ, Xu S. Genetic structure, divergence and admixture of Han Chinese, Japanese and Korean populations. Hereditas 2018;155:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889524</ArticleId><ArticleId IdType="pubmed">29636655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakstis AJ, Gurkan C, Dogan M, et al. . Genetic relationships of European, Mediterranean, and SW Asian populations using a panel of 55 AISNPs. Eur J Hum Genet 2019;27:1885&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871633</ArticleId><ArticleId IdType="pubmed">31285530</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JH, Kwon MJ, Choi WJ, et al. . Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2013;34:1311.e7&#x2013;1311.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23088937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Oh KW, Kwon MJ, et al. . Identification of mutations in Korean patients with amyotrophic lateral sclerosis using multigene panel testing. Neurobiol Aging 2016;37:209.e209&#x2013;209.e216.</Citation><ArticleIdList><ArticleId IdType="pubmed">26601740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon MJ, Baek W, Ki CS, et al. . Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS. Neurobiol Aging 2012;33:1017.e17&#x2013;1017.e23.</Citation><ArticleIdList><ArticleId IdType="pubmed">22244934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Sone J, Atsuta N, et al. . Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging 2016;39:219.e1&#x2013;219.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26742954</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>